Simplex Trading’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-108,500
| Closed | -$10.3M | – | 10181 |
|
|
2025
Q2 | $10.3M | Buy |
108,500
+26,500
| +32% | +$1.96M | 0.01% | 877 |
|
|
2025
Q1 | $5.21M | Buy |
82,000
+65,400
| +394% | +$3.91M | ﹤0.01% | 1278 |
|
|
2024
Q4 | $770K | Sell |
16,600
-138,100
| -89% | -$5.18M | ﹤0.01% | 3117 |
|
|
2024
Q3 | $4.45M | Sell |
154,700
-3,200
| -2% | -$78.8K | ﹤0.01% | 1585 |
|
|
2024
Q2 | $2.28M | Buy |
157,900
+138,600
| +718% | +$2.02M | ﹤0.01% | 2079 |
|
|
2024
Q1 | $310K | Sell |
19,300
-15,700
| -45% | -$271K | ﹤0.01% | 4352 |
|
|
2023
Q4 | $695K | Buy |
35,000
+25,100
| +254% | +$371K | ﹤0.01% | 3371 |
|
|
2023
Q3 | $161K | Buy |
9,900
+7,200
| +267% | +$139K | ﹤0.01% | 4593 |
|
|
2023
Q2 | $57K | Sell |
2,700
-4,200
| -61% | -$89.6K | ﹤0.01% | 5720 |
|
|
2023
Q1 | $138K | Sell |
6,900
-17,400
| -72% | -$376K | ﹤0.01% | 4783 |
|
|
2022
Q4 | $634K | Buy |
24,300
+23,900
| +5,975% | +$318K | ﹤0.01% | 2930 |
|
|
2022
Q3 | $4K | Buy |
+400
| New | +$3.37K | ﹤0.01% | 8981 |
|
|
2022
Q1 | – | Sell |
-21,500
| Closed | -$144K | – | 11488 |
|
|
2021
Q4 | $144K | Buy |
21,500
+16,000
| +291% | +$81.7K | ﹤0.01% | 5664 |
|
|
2021
Q3 | $33K | Hold |
5,500
| – | – | ﹤0.01% | 8010 |
|
|
2021
Q2 | $35K | Buy |
5,500
+5,445
| +9,900% | +$37.8K | ﹤0.01% | 8093 |
|
|
2021
Q1 | $1K | Buy |
+55
| New | +$456 | ﹤0.01% | 8587 |
|
Other funds holding VRNA
Simplex Trading's VRNA Position: Q4 2025 in Review
Simplex Trading sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 2,641 shares — an estimated $281K sold.
Simplex Trading first reported a position in VRNA in Q4 2021 and held it in 12 quarters. The position peaked at $1.86M in Q4 2022. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Simplex Trading reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 2,641 Verona Pharma shares in Q4 2025, an estimated $281K.
- Simplex Trading first reported a position in Verona Pharma in Q4 2021 and held it in 12 quarters.
- Simplex Trading's Verona Pharma position peaked at $1.86M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.